Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 14
Policy
Policy | 24 May 2021

NATCO Pharma receives USFDA approval for Lenalidomide capsules

NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.

Policy
Policy | 10 May 2021

DCGI approves anti-COVID drug developed by DRDO

The drug accumulates in the virus infected cells and prevents virus growth by stopping viral synthesis and energy production

Policy
Policy | 20 April 2021

Indian pharma industry registers 18% exports growth: Narendra Modi

Essential medicines were made available to more than 150 countries around the world during the pandemic

Policy
Policy | 14 April 2021

Pharma PLI to increase exports

Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28

Policy
Policy | 09 April 2021

Pharma sector has both brainpower and manpower to drive growth: Mandaviya

The government has taken all the effective measures to make healthcare affordable

Policy
Policy | 15 January 2021

Pan-India COVID-19 vaccination drive to cover 300,000 persons per day

This vaccination programme is based on the principles of priority groups to be vaccinated and health care workers both in the government and private sectors including ICDS workers will receive the vaccine during this phase.

Policy
Policy | 13 January 2021

LASA receives WHO nod for its Ratnagiri unit

Lasa Supergenerics Limited has received WHO GMP Certificate for its manufacturing facility situated at Khed in Ratnagiri.

Policy
Policy | 11 January 2021

States need to capture vaccination data: R. S. Sharma

Their feedback and the consequent changes in software/protocols based on those inputs were deliberated upon.

Startup

Digitization